This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Companies in highly regulated industries like healthcare and finance are restricted not only in what they can say but the context of what they say and how they can say it. Pharmaceutical advertising, even if as innocuous as a piece of conference swag with the brand name and logo of a drug featured on it, may need clearance from the FDA.
Even though marketing scored an overall 64% on Kantaqr’s Inclusion Index, ahead of the next highest sector, Health and Pharmaceuticals. So that’s all right then? The post Marketing still needs to do more in diversity stakes says WFA first appeared on More About Advertising.
The gambling, adult entertainment, pharmaceutical, finance and medical industries all have their own strict, nuanced regulations and laws they have to consider, making it more difficult for them to get their brand in front of their intended audience.
The good news is that companies in certain industries experienced a major increase in web traffic including finance, healthcare, food, exercise gear, and news outlets. These verticals include agriculture, construction, energy, retail, manufacturing, real estate, and travel, just to name a few.
Hearst’s new sales structure focuses on categories versus publications : Hearst’s sales and marketing team will now focus on one of five advertising categories: fashion/luxury, beauty/wellness and retail, home and design, food and pharmaceuticals or travel, tech, finance and outdoor, according to Adweek.
The Week for Publishers Vice Media Hires Interim Finance Chief as Buyer Search Continues Vice Media has hired Mark Del Priore, director of AlixPartners, a specialist in company turnarounds, as its new finance chief according to the Wall Street Journal.
It was revealed that the billion-dollar company actively breached consumers' trust in them during a trial that resulted in the pharmaceutical company “ pleading guilty to three federal criminal charges for its role in creating the nation's opioid crisis and will pay more than $8 billion and close down the company.”
We have a company in Asia using our data clean rooms in the trade finance sector to collaborate with logistics data for tracking and monitoring cargo shipping data. We also work with numerous pharmaceutical companies on market share data inside the data clean room. And they will always ask questions.
Pharmaceuticals giant Bayer, which first began developing their in-housing operations back in 2017, was reportedly able to reduce its programmatic buying costs by over $10 million in just the first six weeks. Bite off only what you can chew.
Pharmaceuticals giant Bayer, which first began developing their in-housing operations back in 2017, was reportedly able to reduce its programmatic buying costs by over $10 million in just the first six weeks.
Measurement Firm Happydemics Raises 13 Million in Series B Funding Happydemics, a Paris-based ad tech firm, announced it has raised 13 million in a Series B funding round, led by Wille Finance and Adelie Capital. “Our Brand lift technology delivers exactly that.
billion loan to help finance any moves it might wish to make next year relating to German TV business ProSiebenSat.1, Restrictions on pharmaceutical ads look likely, says Madison and Wall’s CEO, CFA and principal Brian Wieser. And this would hit TV particularly hard, since pharmaceutical companies invest heavily in TV.
X is Barely Breaking Even as Financers Prepare Debt Sell-Off Elon Musks X is barely breaking even, according to an internal email from Musk seen by The Verge. “By marketing the Bauer Media Group, we are strengthening the pharmaceutical expertise in the Ad Alliance portfolio, said Ad Alliance CSO Michael Dorn.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content